Search results

Nonclinical study of JAK1-siRNA in minipigs shows targeted, long-lasting efficacy for inflammatory skin diseases with minimal systemic exposure.

Discover how clinic-ready manufacturing and adaptive clinical trials streamline drug development, prevent delays, conserve your resources, and ensure safety, compliance, and efficiency.

See how Altasciences’ Acceleration Platform helped advance an incretin-based therapy to POC in ~22 months through integrated drug development.

Jeff Plomley discusses how patient-centric blood microsampling can enable at-home, minimally invasive sample collection, and improve accessibility and clinical trial efficiency.